Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085156071> ?p ?o ?g. }
- W2085156071 endingPage "12" @default.
- W2085156071 startingPage "1" @default.
- W2085156071 abstract "The aim of this study was to establish the criteria for methodology of cellular “anti-IGF-I” therapy of malignant tumours and particularly for glioblastoma multiforme. The treatment of primary glioblastoma patients using surgery, radiotherapy, and chemotherapy was followed by subcutaneous injection of autologous cancer cells transfected by IGF-I antisense/triple helix expression vectors. The prepared cell “vaccines” should it be in the case of glioblastomas or other tumours, have shown a change of phenotype, the absence of IGF-I protein, and expression of MHC-I and B7. The peripheral blood lymphocytes, PBL cells, removed after each of two successive vaccinations, have demonstrated for all the types of tumour tested an increasing level of CD8 + and CD8 + 28 + molecules and a switch from CD8 + 11b + to CD8 + 11. All cancer patients were supervised for up to 19 months, the period corresponding to minimum survival of glioblastoma patients. The obtained results have permitted to specify the common criteria for “anti-IGF-I” strategy: characteristics sine qua non of injected “vaccines” (cloned cells IGF-I(−) and MHC-I(+)) and of PBL cells (CD8 + increased level)." @default.
- W2085156071 created "2016-06-24" @default.
- W2085156071 creator A5002067050 @default.
- W2085156071 creator A5009671433 @default.
- W2085156071 creator A5020544439 @default.
- W2085156071 creator A5021224823 @default.
- W2085156071 creator A5024804689 @default.
- W2085156071 creator A5028704012 @default.
- W2085156071 creator A5042013362 @default.
- W2085156071 creator A5062585857 @default.
- W2085156071 creator A5067350666 @default.
- W2085156071 creator A5069950117 @default.
- W2085156071 creator A5071329699 @default.
- W2085156071 creator A5072637040 @default.
- W2085156071 creator A5075737267 @default.
- W2085156071 creator A5081995193 @default.
- W2085156071 creator A5085633883 @default.
- W2085156071 creator A5088240323 @default.
- W2085156071 date "2012-02-14" @default.
- W2085156071 modified "2023-10-17" @default.
- W2085156071 title "Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours" @default.
- W2085156071 cites W1561591381 @default.
- W2085156071 cites W1945007559 @default.
- W2085156071 cites W1967851567 @default.
- W2085156071 cites W1968885277 @default.
- W2085156071 cites W1970320743 @default.
- W2085156071 cites W1971008529 @default.
- W2085156071 cites W1974421192 @default.
- W2085156071 cites W1974545086 @default.
- W2085156071 cites W1977906857 @default.
- W2085156071 cites W1978090158 @default.
- W2085156071 cites W1978922759 @default.
- W2085156071 cites W1979497142 @default.
- W2085156071 cites W1984344046 @default.
- W2085156071 cites W1987784827 @default.
- W2085156071 cites W2005713129 @default.
- W2085156071 cites W2008329506 @default.
- W2085156071 cites W2010508184 @default.
- W2085156071 cites W2011243140 @default.
- W2085156071 cites W2011278852 @default.
- W2085156071 cites W2016236724 @default.
- W2085156071 cites W2016915037 @default.
- W2085156071 cites W2023479489 @default.
- W2085156071 cites W2028404673 @default.
- W2085156071 cites W2028858767 @default.
- W2085156071 cites W2029427865 @default.
- W2085156071 cites W2029852333 @default.
- W2085156071 cites W2040572245 @default.
- W2085156071 cites W2042349690 @default.
- W2085156071 cites W2042730255 @default.
- W2085156071 cites W2053962169 @default.
- W2085156071 cites W2056004289 @default.
- W2085156071 cites W2057418848 @default.
- W2085156071 cites W2059670779 @default.
- W2085156071 cites W2062994475 @default.
- W2085156071 cites W206845671 @default.
- W2085156071 cites W2071347266 @default.
- W2085156071 cites W2074272909 @default.
- W2085156071 cites W2076479500 @default.
- W2085156071 cites W2080719056 @default.
- W2085156071 cites W2092264059 @default.
- W2085156071 cites W2092312916 @default.
- W2085156071 cites W2097888739 @default.
- W2085156071 cites W2098588666 @default.
- W2085156071 cites W2110739278 @default.
- W2085156071 cites W2110994430 @default.
- W2085156071 cites W2113211717 @default.
- W2085156071 cites W2120760471 @default.
- W2085156071 cites W2124078079 @default.
- W2085156071 cites W2128856034 @default.
- W2085156071 cites W2132607958 @default.
- W2085156071 cites W2134677648 @default.
- W2085156071 cites W2137551916 @default.
- W2085156071 cites W2145517225 @default.
- W2085156071 cites W2145616602 @default.
- W2085156071 cites W2147675206 @default.
- W2085156071 cites W2150765090 @default.
- W2085156071 cites W2151046897 @default.
- W2085156071 cites W2160425962 @default.
- W2085156071 cites W2169908182 @default.
- W2085156071 doi "https://doi.org/10.1155/2012/721873" @default.
- W2085156071 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3287029" @default.
- W2085156071 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22400112" @default.
- W2085156071 hasPublicationYear "2012" @default.
- W2085156071 type Work @default.
- W2085156071 sameAs 2085156071 @default.
- W2085156071 citedByCount "7" @default.
- W2085156071 countsByYear W20851560712013 @default.
- W2085156071 countsByYear W20851560712015 @default.
- W2085156071 countsByYear W20851560712018 @default.
- W2085156071 countsByYear W20851560712019 @default.
- W2085156071 countsByYear W20851560712020 @default.
- W2085156071 crossrefType "journal-article" @default.
- W2085156071 hasAuthorship W2085156071A5002067050 @default.
- W2085156071 hasAuthorship W2085156071A5009671433 @default.
- W2085156071 hasAuthorship W2085156071A5020544439 @default.
- W2085156071 hasAuthorship W2085156071A5021224823 @default.
- W2085156071 hasAuthorship W2085156071A5024804689 @default.